Cargando…

Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials

BACKGROUND: Efficient mobilization of hematopoietic stem cells (HSCs) from bone marrow niche into circulation is the key to successful collection and transplantation in patients with hematological malignancies. The efficacy of various HSCs mobilization regimens has been widely investigated, but the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Chengxin, Wu, Guixian, Huang, Xiangtao, Zhang, Yali, Ma, Yanni, Huang, Yarui, Huang, Zhen, Li, Hui, Hou, Yu, Chen, Jieping, Li, Xi, Xu, Shuangnian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939102/ https://www.ncbi.nlm.nih.gov/pubmed/35317856 http://dx.doi.org/10.1186/s13287-022-02802-6

Ejemplares similares

Comparison of the efficacy of hematopoietic stem cell mobilization regimens: a systematic review and network meta-analysis of preclinical studies
por: Luo, Chengxin, et al.
Publicado: (2021)

Prognostic Role of Serum Albumin Level in Patients with Lymphoma Undergoing Autologous Stem Cell Transplantation
por: Luo, Chengxin, et al.
Publicado: (2021)

Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20(+) B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis
por: Luo, Chengxin, et al.
Publicado: (2021)

Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials
por: Luo, Chengxin, et al.
Publicado: (2023)

Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia
por: Sun, Yanni, et al.
Publicado: (2021)

SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression
por: Zhang, Yali, et al.
Publicado: (2021)

The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
por: Wang, Limengmeng, et al.
Publicado: (2014)

Peripheral hematopoietic progenitor cell mobilization for autologous transplantation in hematologic malignancies
por: Marques Jr, José Francisco Comenalli
Publicado: (2011)

Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis
por: Li, Teng, et al.
Publicado: (2021)

Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders
por: Mahmoud, Hossam K., et al.
Publicado: (2015)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies
por: Zahid, Mohammad Faizan, et al.
Publicado: (2014)

Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation
por: Vakil, Erik, et al.
Publicado: (2017)

Total marrow irradiation in hematopoietic stem cell transplantation for hematologic malignancies
por: Kerbauy, Mariana Nassif, et al.
Publicado: (2023)

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update
por: Zhang, Xiao-hui, et al.
Publicado: (2021)

Editorial: Characteristics and behaviors of hematopoietic stem cells and leukemia stem cells in hematologic malignancies
por: Zhang, Haojian, et al.
Publicado: (2022)

The Confirmation of Safety for the Intensified Conditioning Regimens: A Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation for Non-Remission Hematological Malignant Diseases
por: Yoshida, Shuro, et al.
Publicado: (2018)

Coping in caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation
por: Amonoo, Hermioni L., et al.
Publicado: (2022)

Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation
por: Sevcikova, Aneta, et al.
Publicado: (2023)

Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis
por: Xu, Shuangnian, et al.
Publicado: (2015)

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
por: Xuan, Li, et al.
Publicado: (2012)

Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis
por: Chen, Zhe, et al.
Publicado: (2021)

Hematopoietic stem cell mobilization
por: Chang, Hsin-Hou, et al.
Publicado: (2021)

The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology
por: Xu, Lanping, et al.
Publicado: (2018)

Anxiety and Depression of the Patients with Hematological Malignancies during Hospitalization for Hematopoietic Stem Cell Transplantation
por: Seo, Ho-Jun, et al.
Publicado: (2019)

Esophagectomy postallogenic hematopoietic stem cell transplantation for hematologic malignancy: A case series
por: Bolger, Jarlath C., et al.
Publicado: (2022)

Long-term expansion of human hematopoietic stem cells
por: Liang, Guixian, et al.
Publicado: (2023)

Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies
por: Zaghi, Elisa, et al.
Publicado: (2019)

The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients
por: Hakki, Morgan, et al.
Publicado: (2015)

Sexual Function in Women Survivors of Hematologic Malignancy after Autologous Hematopoietic Stem Cell Transplantation
por: Tsatsou, Ioanna, et al.
Publicado: (2023)

The emerging role of Twist proteins in hematopoietic cells and hematological malignancies
por: Merindol, N, et al.
Publicado: (2014)

Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies
por: Fabricius, William A., et al.
Publicado: (2016)

The emerging role of Twist proteins in hematopoietic cells and hematological malignancies
por: Merindol, N, et al.
Publicado: (2014)

Viral Pneumonia in Patients with Hematopoietic Cell Transplantation and Hematologic Malignancies
por: Green, Margaret L.
Publicado: (2017)

Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme
por: Wang, Lu, et al.
Publicado: (2023)

Multiomics of three hematological malignancies in a patient reveal their origin from clonal hematopoietic stem cells
por: Mayeur, Sylvain, et al.
Publicado: (2023)

Unveiling the complexity of transcription factor networks in hematopoietic stem cells: implications for cell therapy and hematological malignancies
por: Benyoucef, Aissa, et al.
Publicado: (2023)

High Doses of Daunorubicin during Induction Therapy of Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Clinical Trials
por: Gong, Qiang, et al.
Publicado: (2015)

Ferroptosis in hematological malignant tumors
por: Liu, Yong, et al.
Publicado: (2023)

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
por: Li, Jiali, et al.
Publicado: (2020)

Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting
por: Hou, Jing-Zhou, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_58jvm4u9mjhoqrj7ku34pl1u1g